|
Candidate asthma and allergy drug passes early test
Science News (blog) By suppressing an inflammation-causing antibody, an experimental drug can lessen allergy and asthma symptoms for months at a time in some people, researchers report in the July 2 Science Translational Medicine. The prospective drug, called quilizumab … |
View full post on asthma – Google News